Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection

Japanese Journal of Infectious Diseases

Volumn 53, Issue 6, 2000, Pages 244-245

  Yamamoto, Yoshihiko ^a,b   Yasuoka, Akira ^a   Yasuoka, Chie ^a   Genka, Ikumi ^a   Teruya, Katsuji ^a   Kikuchi, Yoshimi ^a   Tachikawa, Natsuo ^a   Oka, Shinichi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b Org Pharmaceutical Safety and Res   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; ZIDOVUDINE;

ADULT; AGE; AGED; ARTICLE; BONE MARROW TOXICITY; CASE REPORT; CLINICAL FEATURE; DEATH; DISEASE COURSE; HEMOPHILIA; HOMOSEXUALITY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; LYMPHOCYTE COUNT; MALE; METABOLIC DISORDER; MORTALITY; PNEUMOCYSTIS PNEUMONIA; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOXIC HEPATITIS; TREATMENT OUTCOME; VIRUS LOAD;

AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIDANOSINE; DRUG THERAPY, COMBINATION; FATAL OUTCOME; GRANULOCYTE COLONY-STIMULATING FACTOR; HIV INFECTIONS; HIV-1; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; NEVIRAPINE; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0034461029     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors
2. Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy
3. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
4. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection
5. Severe premature coronary artery disease with protease inhibitors